Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)
19 mai 2022 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., May 19, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has received National Medical Products...
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
13 mai 2022 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., May 13, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the full U.S. commercial launch of its UroLift® 2...
Koelis Announces New Products at American Urology Association (“AUA”) Meeting
11 mai 2022 08h00 HE
|
Koelis
GRENOBLE, France and PRINCETON, N.J., May 11, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in the care of prostate cancer, announced today...
avateramedical robot-assisted surgery system progresses to clinical use
10 mai 2022 04h30 HE
|
avateramedical GmbH
avatera system implemented in first clinical practice at German university hospitalTen successful surgeries in urology patients completed in recent weeksNewly designed, competitive player in the...
Fuisz Pharma LLC Announces Patent Issuance for its Non-Invasive Urological Device to Mitigate the Symptoms of Benign Prostate Hyperplasia (BPH)
18 avr. 2022 08h00 HE
|
FUISZ LLC
Williamson County, TN, April 18, 2022 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC, an affiliate of Fuisz LLC, today announced the first patent issuance for its non-invasive urological device platform to...
Koelis Announces Completion of €10 Million Follow-On Growth Equity Financing with InnovaHealth Partners
14 avr. 2022 19h55 HE
|
InnovaHealth Partners
GRENOBLE, France and PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”) announced today the completion of a €10 million follow-on growth equity financing led...
Inherent Biosciences, Inc. Awarded NIH SBIR Phase I Grant to Commercialize Innovative Diagnosis of Non-Obstructive Azoospermia (The Most Severe Form of Sperm Dysfunction)
13 avr. 2022 09h11 HE
|
Inherent Biosciences Inc
SALT LAKE CITY, April 13, 2022 (GLOBE NEWSWIRE) -- Inherent Biosciences, a biotechnology company pioneering epigenetic medicine, today announced an award from the National Institute of Child Health...
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
11 avr. 2022 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., April 11, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced the launch of the UroLift System in Japan for...
Ablation Devices Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
29 mars 2022 05h00 HE
|
Graphical Research
Pune, India, March 29, 2022 (GLOBE NEWSWIRE) -- The global ablation devices market size is poised to grow at a significant CAGR during the forecast period, as many regions across the world are...
World’s largest kidney stone patient experience survey finds 60% of respondents experienced first kidney stone before the age of 45
07 févr. 2022 04h04 HE
|
Advanced MedTech
Singapore, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Dornier MedTech publishes new insights on World Kidney Stone Day from its digital urology community which garners 45 million patient and...